Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+63.27%
adds when stocks drop
when a holding falls −10%+
Middle response
+28.73%
steady accumulation
Rally response
+2.61%
adds into rallies
when a holding rises +10%+
Top positions · 28
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| RLMDRelmada Therapeutics, In | $43M | 10.3% | — | 0.5 yr |
| — | $37M | 8.8% | — | 0.5 yr |
| LBRXLB Pharmaceuticals Inc C | $34M | 8.1% | — | 0.5 yr |
| DNTHDianthus Therapeutics, I | $31M | 7.5% | — | 0.5 yr |
| RLAYRelay Therapeutics, Inc. | $30M | 7.1% | — | 0.5 yr |
| ANROAlto Neuroscience, Inc. | $29M | 7.0% | — | 0.5 yr |
| CNTACentessa Pharmaceuticals | $19M | 4.7% | — | 0.5 yr |
| SVRASavara Inc. | $18M | 4.4% | — | 0.5 yr |
| KALVKalVista Pharmaceuticals | $18M | 4.3% | — | 0.5 yr |
| PCVXVaxcyte, Inc. | $14M | 3.4% | — | 0.5 yr |
| ELVNEnliven Therapeutics, In | $13M | 3.1% | — | 0.5 yr |
| — | $13M | 3.0% | — | 0.5 yr |
| ENTAEnanta Pharmaceuticals, | $12M | 2.8% | — | 0.5 yr |
| ALKSAlkermes plc | $11M | 2.7% | — | 0.3 yr |
| CATXPerspective Therapeutics | $11M | 2.6% | — | 0.3 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology80.8%$336M
Unknown15.3%$64M
Medical - Devices2.6%$11M
Shell Companies1.2%$5M
Country
US76.1%
Unknown15.3%
GB4.7%
IE2.7%
KY1.2%
Top 5: 41.9% · Top 10: 65.8% · Top 25: 97.2%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 15
| ANRO Alto Neuroscience, Inc. | +$25M |
| CNTA Centessa Pharmaceuticals plc | +$16M |
| RLMD Relmada Therapeutics, Inc. | +$15M |
| ALKS Alkermes plcnew | +$11M |
| CATX Perspective Therapeutics, Inc.new | +$11M |
| KALV KalVista Pharmaceuticals, Inc. | +$10M |
| LBRX LB Pharmaceuticals Inc Common | +$9M |
| ALMS Alumis Inc. Common Stocknew | +$9M |
| ENTA Enanta Pharmaceuticals, Inc. | +$7M |
| DNTH Dianthus Therapeutics, Inc. | +$6M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $416M | 28 | +46.91% | -4.37% | +51.28% | -0.03B |
| 2025-12-31 | $303M | 27 | — | — | — | — |